Overview
ALHC market data
Price History
ALHC price chart
Valuation & Profitability
- P/E (TTM)
- 70.23 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.00 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.09 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 0.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $13.05 – $25.12 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.9B · P/B 22.04 · P/S 0.62.
Company News
Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors with Significant Losses to Contact the Firm Before September 22, 2026Globenewswire Inc · Aug 7, 2026, 3:15 PM
Lowey Dannenberg, P.C. is Investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for Potential Violations of the Federal Securities LawsGlobenewswire Inc · Aug 4, 2026, 8:15 PM
JP Morgan Maintains Overweight on Alignment Healthcare, Lowers Price Target to $22Benzinga · Aug 4, 2026, 6:29 PM
Raymond James Downgrades Alignment Healthcare to Outperform, Lowers Price Target to $19Benzinga · Aug 3, 2026, 6:50 PM
Alignment Healthcare Raises FY2026 Sales Guidance from $5.160B-$5.205B to $5.195B-$5.225B vs $5.189B EstBenzinga · Jul 30, 2026, 8:02 PM
Alignment Healthcare Sees Q3 Sales $1.300B-$1.320B vs $1.315B EstBenzinga · Jul 30, 2026, 8:02 PM
Alignment Healthcare Q2 EPS $0.17 Beats $0.13 Estimate, Sales $1.336B Beat $1.310B EstimateBenzinga · Jul 30, 2026, 8:01 PM
Kaplan Fox Encourages Alignment Healthcare, Inc. (NASDAQ: ALHC) Investors to Learn More About the Investigation of Potential Securities Law ViolationsGlobenewswire Inc · Jul 29, 2026, 3:15 PM
Kaplan Fox Reminds Investors of Alignment Healthcare, Inc. (NASDAQ: ALHC) to Contact the Firm Regarding an Investigation of Potential Securities Law ViolationsGlobenewswire Inc · Jul 22, 2026, 2:15 PM
UNCY: Unicycive Therapeutics Investors with Losses Should Contact Block & Leviton About Securities Fraud InvestigationGlobenewswire Inc · Jul 13, 2026, 7:15 PM